… Medical, Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] … acquisition integration. Adjusted diluted earnings per share for the quarter … it was when we do Hospira, is on track, it… simpler than we do with Hospira. It's scheduled …

… (NASDAQ:AVAH) Q3 2023 Earnings Call Transcript November 10, 2023 … Healthcare Holdings Third Quarter 2023 Earnings Conference Call. Today’s … wage rates while also earning value-based payments for … certainly were pleased with the Hospira final rule. And I …

… Inc. Third Quarter 2023 Earnings Conference Call [Operator Instructions]. … losses when we purchased Hospira, when customer losses were … hopefully combined with improving earnings, post our production … During the second quarter earnings call, we provided updated …

… Medical, Inc. misses on earnings expectations. Reported EPS is … Medical Second Quarter 2023 Earnings Conference Call. [Operator Instructions … losses when we purchased Hospira when customer losses were … acquisition. Adjusted diluted earnings per share for the …

… 2023 Acme United Corporation beats earnings expectations. Reported EPS is … United Corporation Second Quarter 2023 Earnings. At this time, … Exchange Commission in our current earnings release. Walter Johnsen: … section of the Pfizer Hospira facility, which is 7 …

… pump losses when we purchased Hospira, when customer losses were … feels very similar to Hospira and our collective previous … sense. Like with the Hospira transaction, we’re changing … Medical acquisition. Adjusted diluted earnings per share for the quarter …

… feels very similar to Hospira and our collective previous … spitalier on Unsplash Unlike the Hospira transaction, where a lot … important steps because like Hospira, they allow for next … Medical acquisition. Adjusted diluted earnings per share for the quarter …

… Medical, Inc. Second Quarter 2022 Earnings Conference Call. [Operator Instructions]. … feels very similar to Hospira and our previous experience, … , just like with the Hospira transaction, where we have … we lived through in Hospira, where the products were …

… anemia, Retacrit. Hospira's most recent quarterly earnings saw profits … that includes biosimilars, a Hospira specialty. The New York- … 12 cents per share to earnings in the year after … generic drug competition. The Hospira deal should help Pfizer increase …

… similar situation when we acquired Hospira and our team worked … the businesses. Adjusted diluted earnings per share for the first … A little bit like the Hospira story right consumables, it took … 1.5 years to get Hospira consumables moving, but it became …